Mercor turned a simple hiring problem into critical AI infrastructure. Whether it IPOs or gets acquired, the company’s grip on specialized human talent puts it squarely in the path of every dollar spent training the next generation of AI models.
Vercel’s path from open-source project to potential IPO shows where web development is headed. With tender offers slowing public markets, investors should watch developer adoption and wait for transparent financials.
Figure AI is building the autonomous intelligent robots depicted in science fiction for decades. The robots think and act like humans, making them capable of doing dangerous and undesirable jobs.
Voice AI companies developing speech generation technology represent compelling investment opportunities, with pre-IPO and public market strategies offering different risk profiles for investors.
Perplexity may be the Google Search disruptor coveted by VCs and rival tech behemoths. Follow along as Perplexity rides the AI wave to a more accurate and transparent search experience.
Harvey’s rapid path to a potential IPO reflects unusual confidence in legal AI’s winner-take-most dynamics, though its revenue multiple suggests significant repricing risk once public market scrutiny begins.
Explore ways to invest in OpenEvidence stock before, during, and after a future IPO—covering pre-IPO access, broker participation, valuation risks, and what retail investors should realistically expect.
Explore opportunities to invest in the Dataiku IPO, reported to be arriving in the first half of 2026. Invest in leading AI, fintech, and defense startups via Fundrise Venture. $10…
AI software gets most of the mainstream press attention. But Cerebras aims to be a premium hardware platform for AI computing, competing against NVIDIA with a different approach designing chips and processing data.
Explore opportunities to invest in the Motive IPO, which is expected in Q1 after filing on December 23rd. A January 16th report by The Information has revealed the company has…
Abridge’s rapid growth and strong clinical ties position it as a standout in healthcare AI, but limited share access and high valuations mean investors should track its progress carefully ahead of any future IPO.
Explore opportunities to invest in Safe Superintelligence stock before a potential upcoming IPO. The company is private, but investors may find opportunities to invest via secondary marketplaces or venture capital…